BioSpace published the announcement of Fesarius Therapeutics' oversubscribed $20 million Series A financing, led by Jefferson Life Sciences and backed by NY Ventures and the American Society of Plastic Surgeons.
BioSpace: FesariusTherapeutics Closes Oversubscribed $20M Series A
